MGX
Metagenomi, Inc. Common Stock
NASDAQ · Healthcare · Biotechnology · US
$1.17
+0.86%0
Insider buys (3m)
3
Insider sells (3m)
-$9.3K
Net value (3m)
-9.3%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Jun 11, 2026 | Dere Willard H · director | A-Award | 21,000 | $1.23 |
| Jun 11, 2026 | Reid Laurence · director | A-Award | 17,400 | $1.23 |
| Jun 11, 2026 | BJERKHOLT ERIC · director | A-Award | 21,000 | $1.23 |
| Jun 11, 2026 | Eckhardt Juergen · director | A-Award | 21,000 | $1.23 |
| Jun 10, 2026 | Wein Matthew · officer: See Remarks | Sale | 558 | $1.30 |
| Jun 10, 2026 | Wapnick Pamela · officer: Chief Financial Officer | Sale | 2,884 | $1.30 |
| Jun 10, 2026 | Irish Jian · director, officer: See Remarks | Sale | 3,737 | $1.30 |
| Apr 3, 2026 | Wapnick Pamela · officer: Chief Financial Officer | A-Award | 144,000 | $1.34 |
| Apr 3, 2026 | Wapnick Pamela · officer: Chief Financial Officer | A-Award | 24,000 | $0.00 |
| Apr 3, 2026 | Wein Matthew · officer: See Remarks | A-Award | 68,000 | $1.34 |
| Apr 3, 2026 | Wein Matthew · officer: See Remarks | A-Award | 11,000 | $0.00 |
| Apr 3, 2026 | Irish Jian · director, officer: See Remarks | A-Award | 276,000 | $1.34 |
| Apr 3, 2026 | Irish Jian · director, officer: See Remarks | A-Award | 46,000 | $0.00 |
| Mar 9, 2026 | Wapnick Pamela · officer: Chief Financial Officer | Sale | 1,581 | $1.60 |
| Mar 9, 2026 | Wein Matthew · officer: See Remarks | Sale | 482 | $1.60 |
| Mar 9, 2026 | Irish Jian · director, officer: Chief Executive Officer | Sale | 1,607 | $1.60 |
| Dec 8, 2025 | Wapnick Pamela · officer: Chief Financial Officer | Sale | 1,576 | $1.77 |
| Dec 8, 2025 | Irish Jian · director, officer: Chief Executive Officer | Sale | 1,602 | $1.77 |
| Dec 8, 2025 | Wein Matthew · officer: See Remarks | Sale | 199 | $1.77 |
| Dec 8, 2025 | Thomas Brian C. · director | Sale | 3,830 | $1.77 |
| Dec 1, 2025 | Wein Matthew · officer: See Remarks | Sale | 199 | $1.81 |
| Dec 1, 2025 | Wapnick Pamela · officer: Chief Financial Officer | A-Award | 120,000 | $1.60 |
| Dec 1, 2025 | Wapnick Pamela · officer: Chief Financial Officer | Sale | 1,576 | $1.81 |
| Dec 1, 2025 | Irish Jian · director, officer: Chief Executive Officer | A-Award | 211,000 | $1.60 |
| Dec 1, 2025 | Irish Jian · director, officer: Chief Executive Officer | A-Award | 37,500 | $1.60 |
| Dec 1, 2025 | Irish Jian · director, officer: Chief Executive Officer | Sale | 1,602 | $1.81 |
| Dec 1, 2025 | Irish Jian · director, officer: Chief Executive Officer | A-Award | 225,000 | $1.60 |
| Dec 1, 2025 | Wein Matthew · officer: See Remarks | A-Award | 96,000 | $1.60 |
| Dec 1, 2025 | Thomas Brian C. · director | Sale | 2,701 | $1.81 |
| Sep 2, 2025 | Reid Laurence · director | A-Award | 42,000 | $1.82 |
Institutional positioning
13F filings over the trailing two quarters
New 5Increased 10Reduced 15Sold out 45
| Filer | Action | Shares | Filed |
|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 1,057,944 | May 15, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | Increased | 787,900 | May 14, 2026 |
| CATALIO CAPITAL MANAGEMENT, LP | Unchanged | 528,993 | May 15, 2026 |
| Catalio Capital Management, LP | Unchanged | 528,993 | Aug 14, 2026 |
| PEAPOD LANE CAPITAL LLC | Increased | 516,761 | May 4, 2026 |
| TWO SIGMA INVESTMENTS, LP | Increased | 496,767 | May 15, 2026 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | Unchanged | 395,800 | May 15, 2026 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | New Position | 382,153 | May 15, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 358,200 | May 15, 2026 |
| PURA VIDA INVESTMENTS, LLC | Unchanged | 264,391 | May 12, 2026 |
| BLACKROCK, INC. | Increased | 230,134 | May 13, 2026 |
| WELLS FARGO & COMPANY/MN | Increased | 202,138 | Jul 8, 2026 |
| VANGUARD FIDUCIARY TRUST CO | New Position | 170,174 | May 8, 2026 |
| MILLENNIUM MANAGEMENT LLC | Reduced | 170,104 | May 15, 2026 |
| JANE STREET GROUP, LLC | Reduced | 151,440 | May 12, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Jun 11, 2026